115 related articles for article (PubMed ID: 15640959)
21. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
[TBL] [Abstract][Full Text] [Related]
22. VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration.
Li D; Zhang C; Song F; Lubenec I; Tian Y; Song QH
Microvasc Res; 2009 Mar; 77(2):134-42. PubMed ID: 18948122
[TBL] [Abstract][Full Text] [Related]
23. Expression of Ki-67, transforming growth factor beta1, and B-cell lymphoma-leukemia-2 in liver tissue of patients with chronic liver diseases.
Piekarska A; Piekarski J; Omulecka A; Szymczak W; Kubiak R
J Gastroenterol Hepatol; 2006 Apr; 21(4):700-10. PubMed ID: 16677156
[TBL] [Abstract][Full Text] [Related]
24. Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgery.
Curigliano G; Petit JY; Bertolini F; Colleoni M; Peruzzotti G; de Braud F; Gandini S; Giraldo A; Martella S; Orlando L; Munzone E; Pietri E; Luini A; Goldhirsch A
Breast Cancer Res Treat; 2005 Sep; 93(1):35-40. PubMed ID: 16184456
[TBL] [Abstract][Full Text] [Related]
25. Localization of recognition site between transforming growth factor-beta1 (TGF-beta1) and TGF beta receptor type II: possible implications in breast cancer.
Ivanović V; Demajo M; Todorović-Raković N; Nikolić-Vukosavljević D; Nesković-Konstantinović Z; Krtolica K; Veljković V; Prljić J; Dimitrijević B
Med Hypotheses; 2004; 62(5):727-32. PubMed ID: 15082097
[TBL] [Abstract][Full Text] [Related]
26. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.
Perrone G; Santini D; Vincenzi B; Zagami M; La Cesa A; Bianchi A; Altomare V; Primavera A; Battista C; Vetrani A; Tonini G; Rabitti C
Histopathology; 2005 May; 46(5):561-8. PubMed ID: 15842638
[TBL] [Abstract][Full Text] [Related]
27. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
Banerjee S; Pancholi S; A'hern R; Ghazoui Z; Smith IE; Dowsett M; Martin LA
Clin Cancer Res; 2008 May; 14(9):2656-63. PubMed ID: 18451229
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-beta1, vascular endothelial growth factor, and bone morphogenic protein-7 expression in tacrolimus-induced nephrotoxicity in rats.
Oğütmen B; Tuğlular S; Cakalağaoğlu F; Ozener C; Akoğlu E
Transplant Proc; 2006 Mar; 38(2):487-9. PubMed ID: 16549155
[TBL] [Abstract][Full Text] [Related]
29. Involvement of signaling of VEGF and TGF-beta in differentiation of sinusoidal endothelial cells during culture of fetal rat liver cells.
Yoshida M; Nishikawa Y; Omori Y; Yoshioka T; Tokairin T; McCourt P; Enomoto K
Cell Tissue Res; 2007 Aug; 329(2):273-82. PubMed ID: 17450384
[TBL] [Abstract][Full Text] [Related]
30. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
Park SS; Kim SW
Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
[TBL] [Abstract][Full Text] [Related]
31. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
Jachec W; Foremny A; Domal-Kwiatkowska D; Smolik S; Tomasik A; Mazurek U; Wodniecki J
Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
[TBL] [Abstract][Full Text] [Related]
32. [Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance].
Wang XB; Yang QX; Pei XJ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):860-3. PubMed ID: 16793622
[TBL] [Abstract][Full Text] [Related]
33. Effects of transforming growth factor-beta1 and vascular endothelial growth factor 165 gene transfer on Achilles tendon healing.
Hou Y; Mao Z; Wei X; Lin L; Chen L; Wang H; Fu X; Zhang J; Yu C
Matrix Biol; 2009 Jul; 28(6):324-35. PubMed ID: 19389474
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of TGF beta 1 and TGF beta 3 in human breast carcinoma.
Ghellal A; Li C; Hayes M; Byrne G; Bundred N; Kumar S
Anticancer Res; 2000; 20(6B):4413-8. PubMed ID: 11205281
[TBL] [Abstract][Full Text] [Related]
35. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
36. Visualisation of transforming growth factor-beta 1, tissue kallikrein, and kinin and transforming growth factor-beta receptors on human clear-cell renal carcinoma cells.
Moodley R; Snyman C; Odhav B; Bhoola KD
Biol Chem; 2005 Apr; 386(4):375-82. PubMed ID: 15899700
[TBL] [Abstract][Full Text] [Related]
37. TGF-beta 1 could be a missing link in the interplay between ER and HER-2 in breast cancer.
Todorović-Raković N
Med Hypotheses; 2005; 65(3):546-51. PubMed ID: 15913903
[TBL] [Abstract][Full Text] [Related]
38. TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling.
König HG; Kögel D; Rami A; Prehn JH
J Cell Biol; 2005 Mar; 168(7):1077-86. PubMed ID: 15781474
[TBL] [Abstract][Full Text] [Related]
39. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte 'priming' and increase in transforming growth factor-beta1 mRNA expression are delayed in hypothyroid versus euthyroid rats during liver regeneration.
Moro L; Perlino E; Marra E; Greco M
Int J Mol Med; 2006 Jun; 17(6):1063-8. PubMed ID: 16685417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
